Deep infection after hip arthroplasty: staying current with change

Area of Science:

• Orthopedics
• Infectious Diseases
• Biomedical Engineering

Background:

• Periprosthetic joint infection (PJI) is a severe complication following total hip arthroplasty (THA), occurring in 0.5% to 1.2% of primary procedures.
• PJI can lead to devastating consequences, necessitating complex management strategies.
• Traditional diagnostic methods include serological inflammatory markers and joint fluid microbiological analysis.

Purpose of the Study:

• To provide an updated overview of the burden of periprosthetic joint infection (PJI) after total hip arthroplasty (THA).
• To review current diagnostic and treatment strategies for PJI.
• To highlight challenges posed by resistant organisms and the need for evidence-based treatment guidelines.

Main Methods:

• Literature review and synthesis of recent studies on PJI.
• Analysis of diagnostic approaches, including serological markers and microbiological sampling.
• Evaluation of treatment modalities such as debridement and staged or one-stage revision arthroplasty.

Main Results:

• PJI remains a significant complication with substantial patient impact.
• Diagnostic accuracy and treatment efficacy are continually evolving.
• The emergence of antibiotic-resistant organisms presents a growing challenge in PJI management.

Conclusions:

• There is a critical need for robust, evidence-based guidelines to direct the management of PJI after THA.
• Further research is required to address treatment uncertainties, particularly concerning resistant pathogens.
• Optimizing PJI diagnosis and treatment is essential for improving patient outcomes in THA.